Cubist Systematic Strategies, LLC Oyster Point Pharma, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.1 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$10.17 - $18.96 $86,200 - $160,704
-8,476 Reduced 75.43%
2,761 $50,000
Q3 2021

Nov 15, 2021
BUY
$11.67 - $18.07 $131,135 - $203,052
11,237 New
11,237 $133,000

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email